Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non-small-cell lung cancer

被引:0
|
作者
Naidoo, Jarushka
Johnson, Douglas Buckner
Doran, Charlotte
Wang, Yuexi
Zhang, Yan
Le, Trong Kim
Hopson, Sari
Dreyfus, Brian
Lal, Lincy S.
Vyas, Charmy
Goldstein, Shay
Izadi, Zara
机构
[1] Beaumont RCSI Canc Ctr, Dublin, Ireland
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] ConcertAI, Cambridge, MA USA
[4] Bristol Myers Squibb, Princeton, NJ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6604
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Modeling Tumor Dynamics and Overall Survival in Advanced Non-Small-Cell Lung Cancer Treated with Erlotinib
    Suleiman, Ahmed Abbas
    Frechen, Sebastian
    Scheffler, Matthias
    Zander, Thomas
    Kahraman, Deniz
    Kobe, Carsten
    Wolf, JRgen
    Nogova, Lucia
    Fuhr, Uwe
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (01) : 84 - 92
  • [32] 5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy
    Bjornhart, Birgitte
    Mouritzen, Mette Thune
    Kristiansen, Charlotte
    Schytte, Tine
    Wedervang, Kim
    Pohl, Mette
    Hansen, Karin Holmskov
    ACTA ONCOLOGICA, 2023, 62 (08) : 861 - 870
  • [33] Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
    Young, Philip
    Elghawy, Omar
    Mock, Joseph
    Wynter, Emmett
    Gentzler, Ryan D.
    Martin, Linda W.
    Novicoff, Wendy
    Hall, Richard
    CURRENT ONCOLOGY, 2024, 31 (01) : 260 - 273
  • [34] The association between body composition and overall survival in patients with advanced non-small cell lung cancer
    Liang Fu
    Haiming Ding
    Liupei Mo
    Xiaoyu Pan
    Lijuan Feng
    Shenglian Wen
    Qiaoqing Lan
    Liling Long
    Scientific Reports, 15 (1)
  • [35] Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer
    Voong, Khinh Ranh
    Hazell, Sarah Z.
    Fu, Wei
    Hu, Chen
    Lin, Cheng Ting
    Ding, Kai
    Suresh, Karthik
    Hayman, Jonathan
    Hales, Russell K.
    Alfaifi, Salem
    Marrone, Kristen A.
    Levy, Benjamin
    Hann, Christine L.
    Ettinger, David S.
    Feliciano, Josephine L.
    Peterson, Valerie
    Kelly, Ronan J.
    Brahmer, Julie R.
    Forde, Patrick M.
    Naidoo, Jarushka
    CLINICAL LUNG CANCER, 2019, 20 (04) : E470 - E479
  • [36] The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Sebastian, Nikhil T.
    Stokes, William A.
    Behera, Madhusmita
    Jiang, Renjian
    Gutman, David A.
    Huang, Zhonglu
    Burns, Abigail
    Sukhatme, Vidula
    Lowe, Michael C.
    Ramalingam, Suresh S.
    Sukhatme, Vikas P.
    Moghanaki, Drew
    CLINICAL LUNG CANCER, 2023, 24 (03) : 287 - 294
  • [37] The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
    Sebastian, Nikhil T.
    Stokes, William A.
    Behera, Madhusmita
    Jiang, Renjian
    Gutman, David A.
    Huang, Zhonglu
    Burns, Abigail
    Sukhatme, Vidula
    Lowe, Michael C.
    Ramalingam, Suresh S.
    Sukhatme, Vikas P.
    Moghanaki, Drew
    ONCOLOGIST, 2024,
  • [38] Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors
    Zhao, Dan
    Mambetsariev, Isa
    Li, Haiqing
    Chen, Chen
    Fricke, Jeremy
    Fann, Patricia
    Kulkarni, Prakash
    Xing, Yan
    Lee, Peter P.
    Bild, Andrea
    Massarelli, Erminia
    Koczywas, Marianna
    Reckamp, Karen
    Salgia, Ravi
    LUNG CANCER, 2020, 146 : 174 - 181
  • [39] Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors
    Zhao, Dan
    Mambetsariev, Isa
    Li, Haiqing
    Chen, Chen
    Fricke, Jeremy
    Fann, Patricia
    Kulkarni, Prakash
    Xing, Yan
    Lee, Peter
    Bild, Andrea
    Massarelli, Erminia
    Koczywas, Marianna
    Reckamp, Karen
    Salgia, Ravi
    CANCER RESEARCH, 2020, 80 (16)
  • [40] ASSOCIATION BETWEEN CLINICOPATHOLOGICAL PARAMETERS AND THE EFFICACY OF IMMUNE CHECKPOINT INHIBITOR THERAPY IN PATIENTS WITH BIOPSY-DIAGNOSED NON-SMALL-CELL LUNG CANCER
    Ota, Takahiro
    Takada, Naohide
    Nishikawa, Yoshimi
    Yoshioka, Hidetoshi
    Igarashi, Shuta
    Kobayashi, Yusuke
    Nakamura, Takaya
    Emura, Masahito
    RESPIROLOGY, 2019, 24 : 179 - 180